…n launched and their outcomes are awaited. As of June 2025, the FDA has approved valrubicin, pembrolizumab, nadofaragene firadenove…
National Comprehensive Cancer Network
This institution is selected. Its supporting articles are shown below.
Articles mentioning National Comprehensive Cancer Network
8 articles · page 1 of 1…ls. (P8) Lack of institutional protocolsMost institutes, unlike Tata Hospital, don’t have their own protocols. (P7) Robustness and timely upd…
…their widespread use, also have inherent limitations. Regarding SUS control arms, we also relied on protocols from the ICESP and th…
…iated with improved OS (HR 0.40; CI 0.19 to 0.87; p=0.021). The NCCN presently recommends adjuvant chemotherapy if neoadjuvant chemo…
…st Cancer International Consortium; ML, machine learning; NCCN, National Comprehensive Cancer Network; NPV, negative predictive value; OC, organ confined; PPV, posit…
…eties, including the Society of Interventional Radiology (SIR), Cardiovascular and Interventional Radiological Society of Europe (CIRSE), and National Comprehensive Cancer Network (NCCN), endo…
…al Oncology-Magnitude of Clinical Benefit Scale3 as well as the Common Sense Oncology initiative.4Scientifically, using an inferior control arm compromises the …
…inal lymphadenopathy, making the tumour inoperable according to National Comprehensive Cancer Network guidelines due to the involvement of essential structures. Neoa…